MMP 13 inhibitors (Amgen)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMMP 13 inhibitors (Amgen)
Drug Alias Namematrix metalloprotease 13 inhibitors (Alantos)MMP 13 inhibitors (Alantos)matrix metalloprotease 13 inhibitors (Amgen)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase 13 inhibitors
TargetsMatrix metalloproteinase 13
Therapy Area/IndicationsOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlantos Pharmaceuticals Holding Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlantos Pharmaceuticals Holding IncAmgen Inc
Active IndicationsN/A
Inactive IndicationsOsteoarthritis

Other Information

ATC CodeN/A
Related LinksN/A